Maria Malm appointed as Regulatory and Clinical Affairs Manager at Galena Pharma

22.06.2026

Galena Pharma has appointed Maria Malm, PhD, as Regulatory and Clinical Affairs Manager as part of its Regulatory Affairs and Product Safety team. She will start in her position on June 22, 2026.

At Galena Pharma, Maria will play a key role especially in clinical evaluations, ensuring compliance with post-market surveillance (PMS) requirements, and maintaining the risk management activities.

She joins Galena Pharma from Aurevia (formerly Labquality Oy), where she has held managerial roles in clinical research. Her experience covers product development, clinical research and documentation, as well as project management related to both vaccines and medical devices.

In her role, Malm reports to Piritta Maunu, Director, Regulatory Affairs and Product Safety.

“We are very pleased to welcome Maria to strengthen our team. Her expertise in clinical evaluations and regulatory processes strongly supports our growth and product development,” says Piritta Maunu.

“Maria’s strong background in clinical research and product development further enhances our capabilities to develop and commercialize MDR-compliant products,” adds CEO Alexej von Bagh.

Galena Pharma is a GMP- and EU MDR -certified pharmaceutical company specializing in manufacturing and developing substance-based medical devices. Galena Pharma provides its own ready-to-market MDR-approved medical devices for in-licensing as private label products. Our focus indication areas are gastrointestinal, female intimate care, cough & cold, pain and skin care.